Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Conferences, Workshops, Symposiums, and Seminars
  4. An miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)
 
conference paper

An miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)

Vilmont, V.  
•
Aebischer, J.  
•
Rochat, C.  
Show more
December 1, 2018
Human Gene Therapy
Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy
  • Details
  • Metrics
Type
conference paper
Web of Science ID

WOS:000453707700257

Author(s)
Vilmont, V.  
Aebischer, J.  
Rochat, C.  
Schneider, B. L.
Date Issued

2018-12-01

Publisher

MARY ANN LIEBERT, INC

Publisher place

New Rochelle

Published in
Human Gene Therapy
Volume

29

Issue

12

Start page

A80

End page

A80

Subjects

Biotechnology & Applied Microbiology

•

Genetics & Heredity

•

Medicine, Research & Experimental

•

Research & Experimental Medicine

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LEN  
PTBTG  
Event nameEvent placeEvent date
Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy

Lausanne, SWITZERLAND

Oct 16-19, 2018

Available on Infoscience
January 3, 2019
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/153281
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés